Equivalent Pharmacokinetics of the Active Metabolite of Ciclesonide With and Without Use of the AeroChamber Plus??? Spacer for Inhalation
- 1 January 2006
- journal article
- research article
- Published by Springer Nature in Clinical Pharmacokinetics
- Vol. 45 (7), 729-736
- https://doi.org/10.2165/00003088-200645070-00007
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- In Vitro metabolism of ciclesonide in human lung and liver precision‐cut tissue slicesBiopharmaceutics & Drug Disposition, 2006
- Identification of enzymes involved in Phase I metabolism of ciclesonide by human liver microsomesEuropean Journal of Drug Metabolism and Pharmacokinetics, 2005
- In Vitro and in Vivo Anti-Inflammatory Activity of the New Glucocorticoid CiclesonideJournal of Pharmacology and Experimental Therapeutics, 2004
- Spacer compliance after discharge following a mild to moderate asthma attackArchives of Disease in Childhood, 2002
- Inhaled and nasal corticosteroids Factors affecting the risks of systemic adverse effectsPharmacology & Therapeutics, 1999
- Comparative efficacy and safety of inhaled corticosteroids in asthma.1999
- The 1997 Asthma Management Guidelines and Therapeutic Issues Relating to the Treatment of AsthmaChest, 1999
- Comparison of the bronchodilator response to albuterol administered by the OptiHaler, the AeroChamber, or by metered dose inhaler alone.1994
- Presentation of results from bioequivalence studies.1992
- Errors in Inhalation Technique and Efficiency in Inhaler Use in Asthmatic ChildrenAllergy, 1986